Why MaxCyte, Inc.’s (MXCT) Stock Is Up 6.30%
As of Monday, November 16, MaxCyte, Inc.’s MXCT share price has surged by 6.30%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Michael Rose
Michael Rose
Jenna Brashear
| Share Statistics | MXCT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $122.8 | $3,632.0 | 24% |
|
| Shares Out (Mil) | 106.8 | 107.2 | 63% |
|
| Institutional Ownership | 97.8% | 89.3% | 75% |
|
| Float (Mil) | 93.7 | 77.0 | 59% |
|
| Beta | na | 1.15 | na |
|
| Avg Daily Volume (000s) | 1,712 | 1,019 | 77% |
|
| Price Change (52-week) |
(21.2%) | 82.0% | 35% |
|
| Growth | MXCT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.7% | 7.5% | 35% |
|
| Net Income (5yr) | (30.5%) | (12.1%) | 13% |
|
| EPS (5yr) | (19.8%) | 2.1% | 14 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (27.7%) | (14.9%) | 22% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 2 | 3 | |
| Current EPS | ($0.073) | ($0.250) | ($0.230) | |
| Month Ago EPS | ($0.073) | ($0.277) | ($0.247) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.063) | ($0.270) | ($0.237) | |
| Year/Year Chg | (12.0%) | (40.3%) | (47.5%) | |
| Financials | MXCT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $31 | $811 | 16% |
|
| Net Income (TTM) (Mil) | ($36) | ($19) | 19% |
|
| EPS (TTM) | ($0.334) | ($0.300) | 30% |
|
| Operating Cash Flow (TTM) (Mil) | ($23) | $52 | 14% |
|
| Net Cash Flow (TTM) (Mil) | $-0 | $3 | 44% |
|
| Long-Term Debt (Q1) (Mil) | $16 | $252 | 31% |
|
| Enterprise Value (Q1) (Mil) | $34 | $3,486 | 15% |
|
| Valuation | MXCT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.79 | 3.59 | 20% |
|
| P/E | na | 35.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 6.6 | na |
|
| Ratios | MXCT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 81.0% | 47.8% | 89% |
|
| Net Margin | (81.4%) | (3.0%) | 9% |
|
| ROA | (17.6%) | (5.4%) | 21% |
|
| ROE | (20.4%) | (5.2%) | 23% |
|
| Liabilities to Assets | 14.0% | 41.5% | 9% |
|
| F-Score | 4 | 5 | 33% |
|
MaxCyte, Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors